The molecular imaging market is projected to grow at a CAGR of 6.25% to reach US$5.151 billion by 2023, from US$3.579 billion in 2017. Molecular imaging delivers a detailed picture of functions in the body at the molecular level, helping in the measurement of chemical and biological processes in the body. Molecular imaging is used to diagnose and manage various cardiovascular, oncology, respiratory, kidney, and thyroid-related disorders. Rising prevalence of such disorders along with growing aging population has driven demand for molecular imaging significantly. Technological advancements in the medical sector will further contribute to the market growth. Growing adoption of hybrid molecular imaging systems is expected to provide a great opportunity for the expansion of the market across potential regional markets. Geographically, North America dominates the global molecular imaging market while the Asia Pacific is expected to be the fastest growing market in the years ahead owing to rising healthcare spending in emerging economies of the region.
This research study examines the current market trends related to the demand, supply, and sales, in addition to the recent developments. Major drivers, restraints, and opportunities have been covered to provide an exhaustive picture of the market. The analysis presents in-depth information regarding the development, trends, and industry policies and regulations implemented in each of the geographical regions.
Further, the overall regulatory framework of the market has been exhaustively covered to offer stakeholders a better understanding of the key factors affecting the overall market environment.
Identification of key industry players in the industry and their revenue contribution to the overall business or relevant segment aligned to the study have been covered as a part of competitive intelligence done through extensive secondary research. Various studies and data published by industry associations, analyst reports, investor presentations, press releases and journals among others have been taken into consideration while conducting the secondary research. Both bottom-up and top-down approaches have been utilized to determine the market size of the overall market and key segments. The values obtained are correlated with the primary inputs of the key stakeholders in the molecular imaging value chain. The last step involves complete market engineering which includes analyzing the data from different sources and existing proprietary datasets while using various data triangulation methods for market breakdown and forecasting.
Market intelligence is presented in the form of analysis, charts, and graphics to help the clients in gaining faster and efficient understanding of the molecular imaging market.
Major industry players profiled as part of the report are GE Healthcare, Siemens Healthcare GmbH, Hologic Inc., and Shimadzu Corporation among others.
Segmentation
The molecular imaging market has been analyzed through the following segments:
By Device Type
Positron Emission Tomography (PET) Scanner
Single Photon Emission Computed Tomography (SPECT) Scanner
Gamma Camera
Nuclear Magnetic Resonance (NMR) Spectrometer
Others
By Application
Cardiovascular
Neurology
Respiratory
Oncology
Other
By End-User
Hospitals
Ambulatory Surgical Centers
Diagnostic Imaging Centers
By Geography
North America
USA
Canada
Mexico
Others
South America
Brazil
Argentina
Others
Europe
Germany
France
United Kingdom
Spain
Others
Middle East and Africa
Saudi Arabia
Israel
Others
Asia Pacific
China
Japan
South Korea
India
Others
.jpg)
